Inhibition of Human Immunodeficiency Virus Infection of Human Lymphocytes by Gangliosides

As the first step in human immunodeficiency virus (HIV) infection, HIV binds to CD4 molecules on the surface of human T lymphocytes. Expression of CD4 by the cells is remarkably modulated by exogenously added gangliosides, which are normal components of the surface of animal cells. We report here that these physiological molecules also clearly inhibited HIV infection of lymphocytes in vitro in a dose‐dependent manner through the selective modulation of CD4 from the cell surface. This raises the possibility of in vivo application of gangliosides as a new strategy for treating acquired immunodeficiency syndrome.

[1]  K. Karjalainen,et al.  Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules , 1989, Nature.

[2]  K. Takatsuki,et al.  Characteristic mode of action of gangliosides in selective modulation of CD4 on human T lymphocytes. , 1989, Biochemical and biophysical research communications.

[3]  Y. Hannun,et al.  Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. , 1989, Science.

[4]  A. Dalgleish,et al.  Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells , 1989, Nature.

[5]  N. Letvin,et al.  Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques , 1989, Nature.

[6]  H. Offner,et al.  Gangliosides induce selective modulation of CD4 from helper T lymphocytes. , 1987, Journal of immunology.

[7]  S. Matsushita,et al.  Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B). , 1987, Japanese journal of cancer research : Gann.

[8]  S. Matsushita,et al.  Characterization of three monoclonal antibodies (VAK3-5) that identify p24, core protein of human immunodeficiency virus, and its precursors. , 1987, Japanese journal of cancer research : Gann.

[9]  Robin A. Weiss,et al.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain , 1986, Cell.

[10]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[11]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[12]  H. Imura,et al.  Neutral glycosphingolipids and gangliosides of bovine thyroid. , 1982, Journal of biochemistry.

[13]  L. Svennerholm.  CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.

[14]  H. Mitsuya,et al.  Strategies for antiviral therapy in AIDS , 1987, Nature.

[15]  Luc Montagnier,et al.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV , 1984, Nature.

[16]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[17]  S. Hakomori.  Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.